Phoenix S&T, Inc. Awarded National Institutes of Health (NIH) SBIR Phase 2 Award for Ultra Fast Separation of Proteins

ELKTON, Md.--(BUSINESS WIRE)--Phoenix S&T, Inc., a leader in the development of high-performance molded devices for high-performance analysis, today announces it has been awarded an NIH Phase 2 SBIR grant to further develop a multidimensional microfluidic chromatographic device that uses nanoparticles as the separation medium for ultrahigh resolution and ultrahigh speed separations of complex proteins. The device will be interfaced with nanospray mass spectrometry for protein detection and identification.
MORE ON THIS TOPIC